Global Japanese Pharmaceutical Company Extends use of Exeevo Omnipresence to Power their European Growth of their Cardiovascular-Metabolic Franchise 

FOR IMMEDIATE RELEASE

New York, New York, August 12, 2022

 

EXEEVO, a global enterprise SaaS leader focused on revolutionizing healthcare professional and personalizing patient experiences for life sciences organizations announces that the second largest Japan-based life sciences company has selected Omnipresence, Exeevo’s customer experience solution to power the growth of their Cardiovascular-Metabolic franchise in Europe building on the success of choosing Omnipresence for their Oncology franchise in 2019.

 

With Exeevo Omnipresence, Oncology and Cardiovascular teams can

design and deliver true personalized omnichannel experiences for their

life sciences customers and HCPs through shared customer journeys

and powerful omnichannel capabilities. Omnipresence’s innovative digital

tools provide the entire organization including commercial, marketing, and

medical affairs, the hybrid operating model they need to succeed.


Derek J. Evans, Chief Growth Officer, Exeevo, states,

“We’re proud to be recognized as a trusted partner and to support our

customers' drive for better commercial strategies with a modern customer

experience platform that can keep up with the pace and complexity of

today’s rapidly changing healthcare landscape.”


Discover Exeevo Omnipresence here

Download the Press Release here

Exeevo Omnipresence Platform Features

About Exeevo

Exeevo is a unified, intelligent and agile digital ecosystem for life sciences organizations to revolutionize health experiences for healthcare teams and patients in their journey towards sustainable health outcomes. Built with Microsoft clouds including Dynamics 365, Azure and Teams as well as Cloud for Healthcare, Exeevo platforms are verticalized for customer and patient experiences, delivered by biopharma, medical devices, biotech and consumer health organizations.